At the start of the pandemic, leaders of medical marketing agencies feared that their businesses would come under intense pressure. They were right – but for a different reason than expected: Agency services were in such high demand that companies couldn’t staff up fast enough to meet it. Here’s how MM+M covered some of the year’s biggest developments.
Founder and chairman Steven Michaelson said in November that the agency will do what it’s always done, “but on such a bigger level.”
The deal followed Fingerpaint’s purchases of Splice Agency, MedThink and others during 2021.
The company, which blew by the $300 million revenue mark in an acquisition-filled 2020, fine-tuned its offering to appeal to an increasingly innovation-minded industry.
MM+M’s Agency 100 revenue chart painted a picture of an industry in the throes of a growth spurt, pandemic or no.
The pandemic led to more work helping clients reimagine healthcare communications for an altered promotional and medical landscape.
Revenue spiked 22% to an MM+M-estimated $421 million in 2020.